NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 261

Law Patients Access Oil 261

Cannabis Law Report

NOVEMBER 2, 2021

The authorization for the marketing and use of the medicine in Brazil, that can be sold exclusively in pharmacies and with a prescription , is foreseen in a resolution of the National Health Surveillance Agency (Anvisa, regulator) published this Friday in the Official Gazette. Source: [link].

Medicine 52

Medicine Chronic Pain Epilepsy Marijuana 52

Cannabis Law Report

AUGUST 15, 2021

As we embark on our next phase of growth, our strong syndicate of expert investors will support us in bringing much-needed innovative treatments to patients suffering from neurological and psychiatric conditions.” The COVID-19 pandemic brought mental health to the public’s attention in a profound way.

Medicine 98

Medicine Research and Development Conditions Treatment 98

Cannabis Law Report

SEPTEMBER 28, 2021

Ryan’s Law” will expand end-of-life treatment and pain relief options for Californians. It is inconceivable to me that, in a state where medical cannabis was legalized more than 25 years ago, those in deepest suffering receiving treatment in our state’s healthcare facilities cannot access this proven, effective, and prescribed treatment,”.

Patients 98

Patients Access Law Treatment 98

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients were granted access to low-THC marijuana oil. In 2019, Georgia’s General Assembly passed Georgia’s Hope Act, which legalized the regulated cultivation of marijuana in the State.

Oil 98

Oil Patients Access THC 98

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Patients, and their treatment, therefore, are the priority.

Access 89

Access Patients Pharmaceutical Education 89

Cannabis Law Report

FEBRUARY 7, 2020

That is Dr Vicki Kotsirilos, GP and Australia’s first authorised GP prescriber of medicinal cannabis. . When fully opened in April, the Releaf Clinic will feature doctors who specialise in prescribing medical cannabis, complementary medicine services, and a shop selling hemp-based products and organic honey. .

Medicine 59

Medicine Dispensary Chronic Pain Patients 59

Cannabis Law Report

MAY 12, 2022

It brings access to NCEs that we can take into Phase 1 studies in the near term, coupled with access to a drug discovery pipeline that we can shape together as our experience ever deepens in the psychedelic drug development space. Beckley Psytech has been working diligently to build a first-class drug development capability.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

JUNE 29, 2021

“While other states are busy implementing sophisticated medical cannabis programs and tackling the country’s opioid epidemic, more than 1 million Texans continue to misuse prescription pain relievers because they are prohibited from accessing effective alternatives. It’s a very real and devastating public health issue.

Treatment 75

Treatment Cultivation Chronic Pain Programs 75

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Veriheal

AUGUST 24, 2022

The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. The Colorado Secretary of State’s office announced earlier this month that the Natural Medicine Health Act received enough qualifying signatures to make it to this November’s ballot. city to do so.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

OCTOBER 12, 2019

There have recently been a series of developments advancing the Australian medicinal cannabis industry. The Narcotic Drugs Act 1967 (Cth) ( ND Act ) establishes a licence and permit scheme to regulate the cultivation, production and manufacture of medicinal cannabis.

Medicine 40

Medicine Research and Development Cultivation Legislation 40

Cannabis Law Report

JANUARY 16, 2020

A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European Medicinal Cannabis Association. The European Medicinal Cannabis Association. Professor Jones. He was a Director of Allergan Inc. Source: [link].

Medicine 59

Medicine Research and Development Pharmaceutical Policy 59

Sensi Seeds

DECEMBER 10, 2018

In 2019 the first official WHO evaluation of the therapeutic value of the cannabis plant in more than 80 years will be released. Today, there is an enormous quantity and varied quality of scientific data, and this study is a fundamental tool that optimizes the way we access it. Nevertheless, things have changed and continue to do so.

Medicine 81

Medicine Research and Development Data Policy 81

Project CBD

FEBRUARY 28, 2023

The following excerpt analyzes CBD marketing trends reported by the American Botanical Council, a membership organization that educates consumers, health care professionals, journalists, and others about the safe and effective use of medicinal plants. Sales appear to have peaked in 2019, when natural channel consumers spent more than $90.7

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

JUNE 26, 2019

Minister for Health Simon Harris TD today signed legislation which will allow for the operation of the Medical Cannabis Access Programme on a pilot basis for five years. The Programme will facilitate access to cannabis-based products for medical use in line with legislation. We have highlighted relevant passages.

Medicine 55

Medicine Access Business Legislation 55

SpeedWeed

JULY 19, 2021

In the March 2019 Cannabis Business Times cover story, Dr. Andrea Small-Howard, co-founder and chief science officer of GB Sciences, said, “My personal mission is to take cannabis-based therapies to the U.S. Just over two years later, Small-Howard, who was promoted to president of the Las-Vegas company in June, is close to her goal.

Medicine 52

Medicine Research and Development Chronic Pain Programs 52

Cannabis Law Report

NOVEMBER 3, 2019

It is estimated that close to a million patients are now seeking access to medicinal cannabis in Australia alone. . Government figures show around 20,000 patients now have approvals for access to legal medicinal cannabis products. . He said on abc radio recently that: “All medicinal cannabis is being imported.

Medicine 81

Medicine Patients Access Cannabis 81

Veriheal

OCTOBER 19, 2022

Warastuti, the mother of Pika Sasi Kirana, is actively lobbying for legal access and research into the plant alongside her daughter’s father, Sunarta. ” Desperate to find a way of relieving her daughter’s suffering, Warastuti proceeded to explore alternative treatment options, one of which was medical marijuana.

Legalization 104

Legalization Research and Development Chronic Pain Treatment 104

Veriheal

SEPTEMBER 11, 2020

Israel has been on the must-watch list in terms of cannabis research and medicinal innovation and now they have made headlines for reading a record high of over 60,000 medical cannabis patients. The country also possesses the most developed medicinal cannabis system outside of North America. The 2019 Cannabis Reform in Israel.

Patients 52

Patients Research and Development Access Treatment 52

Veriheal

OCTOBER 1, 2020

African, Asian, American, European, and other countries have all been following the global cannabis movement, whether for recreational or medicinal purposes. Cannabis is easily accessible, and the regulations are loosening up quite a bit. As a result, the UK proposed medicinal cannabis regulations in 2018. .

Legalization 104

Legalization Oil Medicine Media 104

Cannabis Law Report

SEPTEMBER 20, 2019

20 September 2019. In May 2014, Barnaby Joyce spoke out in support of legalising cannabis medicine: a campaign fronted by a young patient named Dan Haslam. And two years later, the Nationals MP helped open the nation’s first medicinal cannabis farm in memory of Dan, who’d lost his battle with cancer.

Medicine 40

Medicine Patients Access Chronic Pain 40

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. A doctor who applies to the TGA on behalf of a patient must provide a clinical justification.

Legalization 52

Legalization Access Medicine Clinical Trials 52

MMJ Recs

DECEMBER 13, 2023

Let’s take a look at the current state of medical marijuana dispensaries in Texas, examining the legal framework, patient access, and the potential impact on the healthcare landscape. Additionally, patients must have exhausted all other available treatment options without finding relief.

Dispensary 52

Dispensary Patients Marijuana Epilepsy 52

Cannabis Law Report

OCTOBER 3, 2019

The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019. Final Report Reviewing Framework for Medicinal Cannabis Cultivation, Production and Manufacture. The Australian medicinal cannabis industry has received significant commercial, research and policy interest.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Veriheal

JULY 7, 2021

Because, now that they finally have legal access to cannabis, these patients will be able to use cannabis to treat their pain , anxiety , sleep disruption , and more. Put simply, many people aren’t willing to take a medicine if that medicine is deemed illegal in the eyes of their government. I know it will be good for me.

Legalization 117

Legalization Access Policy Chronic Pain 117

NORML

FEBRUARY 22, 2019

Regulate Nationally : The Regulate Marijuana Like Alcohol Act of 2019 (HR 420) seeks to deschedule cannabis from the Controlled Substances Act, thus permitting state governments to regulate these activities as they see fit. Click here to email your lawmakers in support of access in healthcare facilities. Your Highness, Carly.

Legislation 180

Legislation Hemp Compliance Compliance 180

Cannabis Law Report

SEPTEMBER 10, 2019

Tabling of Report on the Review into the 2016 Medicinal Cannabis amendments to the Narcotic Drugs Act 1967. 5 September 2019. Professor McMillan’s Final Report on the Review of the Act was tabled in Parliament today, Thursday 5 September 2019. Click on the image to access the full report.

Medicine 49

Medicine Research and Development Cultivation Access 49

Cannabis Law Report

MAY 12, 2022

Back in 2019, the UK loosened their rules around medical cannabis and allowed a handful of cannabis-derived drugs to be prescribed. Still, only a small number of patients actually get medical cannabis prescriptions and accessibility is still a hot button issue in the country.

Terpenes 52

Terpenes Extraction Advocacy Patients 52

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

OCTOBER 20, 2021

Furthermore, in 2017 the Norwegian parliament voted in favor of a measure to decriminalize drug use, shifting the focus of drug policies towards treatment. Since 2018, the Norwegian Medicines Agency allows doctors approved by the agency to prescribe medical cannabis for patients on a case-by-case basis. Medical cannabis in Norway.

Legalization 59

Legalization Decriminalization Patients Medicine 59

Cannabis Law Report

AUGUST 7, 2022

The CSA divides drugs into schedules according to their assessed risk, categorizing the most dangerous, addictive, and harmful substances that are deemed to not have any recognized medicinal use as “Schedule I.” In 2018, the FDA granted COMPASS Pathways BTD to develop psilocybin therapy for treatment-resistant depression.

Law 74

Law Research and Development Therapy Treatment 74

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

SpeedWeed

AUGUST 22, 2021

A report released by the MS Society states that not nearly enough medical cannabis patients have been able to obtain medical cannabis through the National Health Service (NHS), despite research and firsthand accounts of its effectiveness as a medicine for MS patients. deserves access to effective?treatments.” treatments.” .

Sleep 52

Sleep Access Patients Treatment 52